<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33947017</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>02</Day></DateCompleted><DateRevised><Year>2021</Year><Month>06</Month><Day>02</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>9</Issue><PubDate><Year>2021</Year><Month>Apr</Month><Day>29</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Phenotypic and Functional Consequences of PLT Binding to Monocytes and Its Association with Clinical Features in SLE.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">4719</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms22094719</ELocationID><Abstract><AbstractText>Platelets (PLTs) can modulate the immune system through the release of soluble mediators or through interaction with immune cells. Monocytes are the main immune cells that bind with PLTs, and this interaction is increased in several inflammatory and autoimmune conditions, including systemic lupus erythematosus (SLE). Our aim was to characterize the phenotypic and functional consequences of PLT binding to monocytes in healthy donors (HD) and in SLE and to relate it to the pathogenesis of SLE. We analyzed the phenotypic and functional features of monocytes with non-activated and activated bound PLTs by flow cytometry. We observed that monocytes with bound PLTs and especially those with activated PLTs have an up-regulated HLA-DR, CD86, CD54, CD16 and CD64 expression. Monocytes with bound PLTs also have an increased capacity for phagocytosis, though not for efferocytosis. In addition, monocytes with bound PLTs have increased IL-10, but not TNF-&#x3b1;, secretion. The altered phenotypic and functional features are comparable in SLE and HD monocytes and in bound PLTs. However, the percentages of monocytes with bound PLTs are significantly higher in SLE patients and are associated with undetectable levels of anti-dsDNA antibodies and hematuria, and with normal C3 and albumin/creatinine levels. Our results suggest that PLTs have a modulatory influence on monocytes and that this effect may be highlighted by an increased binding of PLTs to monocytes in autoimmune conditions.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mariscal</LastName><ForeName>Ana&#xed;s</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-1013-4793</Identifier><AffiliationInfo><Affiliation>Immunology Department, Hospital de la Santa Creu I Sant Pau, Biomedical Research Institute Sant Pau (IIB Sant Pau), 08041 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zamora</LastName><ForeName>Carlos</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-2962-678X</Identifier><AffiliationInfo><Affiliation>Laboratory of Inflammatory Diseases, Hospital de la Santa Creu I Sant Pau, Biomedical Research Institute Sant Pau (IIB Sant Pau), 08041 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Magallares</LastName><ForeName>Berta</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Rheumatology Department, Hospital de la Santa Creu I Sant Pau, 08041 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salman-Monte</LastName><ForeName>Tarek Carlos</ForeName><Initials>TC</Initials><Identifier Source="ORCID">0000-0002-4676-0174</Identifier><AffiliationInfo><Affiliation>Rheumatology Department, Parc de Salut Mar/Hospital del Mar-IMIM, 08003 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ortiz</LastName><ForeName>M&#xaa; &#xc0;ngels</ForeName><Initials>M&#xc0;</Initials><Identifier Source="ORCID">0000-0002-1574-9861</Identifier><AffiliationInfo><Affiliation>Laboratory of Inflammatory Diseases, Hospital de la Santa Creu I Sant Pau, Biomedical Research Institute Sant Pau (IIB Sant Pau), 08041 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D&#xed;az-Torn&#xe9;</LastName><ForeName>Cesar</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Rheumatology Department, Hospital de la Santa Creu I Sant Pau, 08041 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Castellv&#xed;</LastName><ForeName>Iv&#xe1;n</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Rheumatology Department, Hospital de la Santa Creu I Sant Pau, 08041 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Corominas</LastName><ForeName>H&#xe9;ctor</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-7738-6787</Identifier><AffiliationInfo><Affiliation>Rheumatology Department, Hospital de la Santa Creu I Sant Pau, 08041 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vidal</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Laboratory of Inflammatory Diseases, Hospital de la Santa Creu I Sant Pau, Biomedical Research Institute Sant Pau (IIB Sant Pau), 08041 Barcelona, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>PI17/00072</GrantID><Agency>Instituto de Salud Carlos III</Agency><Country/></Grant><Grant><GrantID>PI20/00184</GrantID><Agency>Instituto de Salud Carlos III</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>04</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000974">Antibodies, Antinuclear</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015703">Antigens, CD</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006684">HLA-DR Antigens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C508609">IL10 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008562">Membrane Glycoproteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C084882">P-selectin ligand protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014409">Tumor Necrosis Factor-alpha</NameOfSubstance></Chemical><Chemical><RegistryNumber>130068-27-8</RegistryNumber><NameOfSubstance UI="D016753">Interleukin-10</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000974" MajorTopicYN="N">Antibodies, Antinuclear</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015703" MajorTopicYN="N">Antigens, CD</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017209" MajorTopicYN="N">Apoptosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001792" MajorTopicYN="N">Blood Platelets</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005434" MajorTopicYN="N">Flow Cytometry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006684" MajorTopicYN="N">HLA-DR Antigens</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016753" MajorTopicYN="N">Interleukin-10</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="N">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008562" MajorTopicYN="N">Membrane Glycoproteins</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009000" MajorTopicYN="N">Monocytes</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009504" MajorTopicYN="N">Neutrophils</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010587" MajorTopicYN="N">Phagocytosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014409" MajorTopicYN="N">Tumor Necrosis Factor-alpha</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">immune modulation</Keyword><Keyword MajorTopicYN="N">lupus</Keyword><Keyword MajorTopicYN="N">monocytes</Keyword><Keyword MajorTopicYN="N">platelets</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>3</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>4</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>4</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>5</Month><Day>5</Day><Hour>1</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>5</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33947017</ArticleId><ArticleId IdType="pmc">PMC8125177</ArticleId><ArticleId IdType="doi">10.3390/ijms22094719</ArticleId><ArticleId IdType="pii">ijms22094719</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Semple J.W., Italiano J.E., Freedman J. Platelets and the immune continuum. Nat. Rev. Immunol. 2011;11:264&#x2013;274. doi: 10.1038/nri2956.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri2956</ArticleId><ArticleId IdType="pubmed">21436837</ArticleId></ArticleIdList></Reference><Reference><Citation>Tunjungputri R.N., van der Ven A.J., Riksen N., Rongen G., Tacke S., van den Berg T.N.A.D., Fijnheer R., Gomes M.E., Dinarello C.A., van de Veerdonk F.L., et al. Differential effects of platelets and platelet inhibition by ticagrelor on TLR2- and TLR4-mediated inflammatory responses. Thromb. Haemost. 2015;113:1035&#x2013;1045.</Citation><ArticleIdList><ArticleId IdType="pubmed">25716539</ArticleId></ArticleIdList></Reference><Reference><Citation>Gros A., Ollivier V., Ho-Tin-No&#xe9; B. Platelets in inflammation: Regulation of leukocyte activities and vascular repair. Front. Immunol. 2015;6:1&#x2013;8. doi: 10.3389/fimmu.2014.00678.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2014.00678</ArticleId><ArticleId IdType="pmc">PMC4285099</ArticleId><ArticleId IdType="pubmed">25610439</ArticleId></ArticleIdList></Reference><Reference><Citation>Kral J.B., Schrottmaier W.C., Salzmann M., Assinger A. Platelet Interaction with Innate Immune Cells. Transfus. Med. Hemotherapy. 2016;43:78&#x2013;88. doi: 10.1159/000444807.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000444807</ArticleId><ArticleId IdType="pmc">PMC4872052</ArticleId><ArticleId IdType="pubmed">27226790</ArticleId></ArticleIdList></Reference><Reference><Citation>Herter J.M., Rossaint J., Zarbock A. Platelets in inflammation and immunity. J. Thromb. Haemost. 2014;12:1764&#x2013;1775. doi: 10.1111/jth.12730.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.12730</ArticleId><ArticleId IdType="pubmed">25224706</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrell C.N., Aggrey A.A., Chapman L.M., Modjeski K.L. Review Article Emerging roles for platelets as immune and in fl ammatory cells. Blood. 2014;123:2759&#x2013;2767. doi: 10.1182/blood-2013-11-462432.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2013-11-462432</ArticleId><ArticleId IdType="pmc">PMC4007605</ArticleId><ArticleId IdType="pubmed">24585776</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahn K.C., Jun A.J., Pawar P., Jadhav S., Napier S., McCarty O.J.T., Konstantopoulos K. Preferential binding of platelets to monocytes over neutrophils under flow. Biochem. Biophys. Res. Commun. 2005;329:345&#x2013;355. doi: 10.1016/j.bbrc.2005.01.146.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2005.01.146</ArticleId><ArticleId IdType="pubmed">15721313</ArticleId></ArticleIdList></Reference><Reference><Citation>Joseph J.E., Harrison P., Mackie I.J., Isenberg D.A., Machin S.J. Increased circulating platelet-leucocyte complexes and platelet activation in patients with antiphospholipid syndrome, systemic lupus erythematosus and rheumatoid arthritis. Br. J. Haematol. 2001;115:451&#x2013;459. doi: 10.1046/j.1365-2141.2001.03101.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2141.2001.03101.x</ArticleId><ArticleId IdType="pubmed">11703349</ArticleId></ArticleIdList></Reference><Reference><Citation>Li N., Hu H., Lindqvist M., Wikstr&#xf6;m-Jonsson E., Goodall A.H., Hjemdahl P. Platelet-leukocyte cross talk in whole blood. Arterioscler. Thromb. Vasc. Biol. 2000;20:2702&#x2013;2708. doi: 10.1161/01.ATV.20.12.2702.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.ATV.20.12.2702</ArticleId><ArticleId IdType="pubmed">11116075</ArticleId></ArticleIdList></Reference><Reference><Citation>Zamora C., Riudavets M., Anguera G., Alserawan L., Sullivan I., Barba A., Serra J., Ortiz M.A., Gallardo P., Perea L., et al. Circulating leukocyte&#x2013;platelet complexes as a predictive biomarker for the development of immune-related adverse events in advanced nonsmall cell lung cancer patients receiving anti-PD-(L)1 blocking agents. Cancer Immunol. Immunother. 2021:1&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">33388994</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarbock A., M&#xfc;ller H., Kuwano Y., Ley K. PSGL-1-dependent myeloid leukocyte activation. J. Leukoc. Biol. 2009;86:1119&#x2013;1124. doi: 10.1189/jlb.0209117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.0209117</ArticleId><ArticleId IdType="pubmed">19703898</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuligowski M.P., Kitching A.R., Hickey M.J. Leukocyte Recruitment to the Inflamed Glomerulus: A Critical Role for Platelet-Derived P-Selectin in the Absence of Rolling. J. Immunol. 2006;176:6991&#x2013;6999. doi: 10.4049/jimmunol.176.11.6991.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.176.11.6991</ArticleId><ArticleId IdType="pubmed">16709860</ArticleId></ArticleIdList></Reference><Reference><Citation>Da Costa Martins P.A., van Gils J.M., Mol A., Hordijk P.L., Zwaginga J.J. Platelet binding to monocytes increases the adhesive properties of monocytes by up-regulating the expression and functionality of beta1 and beta2 integrins. J. Leukoc. Biol. 2006;79:499&#x2013;507. doi: 10.1189/jlb.0605318.</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.0605318</ArticleId><ArticleId IdType="pubmed">29350799</ArticleId></ArticleIdList></Reference><Reference><Citation>Weyrich A.S., Elstad M.R., McEver R.P., McIntyre T.M., Moore K.L., Morrissey J.H., Prescott S.M., Zimmerman G.A. Activated platelets signal chemokine synthesis by human monocytes. J. Clin. Investig. 1996;97:1525&#x2013;1534. doi: 10.1172/JCI118575.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI118575</ArticleId><ArticleId IdType="pmc">PMC507213</ArticleId><ArticleId IdType="pubmed">8617886</ArticleId></ArticleIdList></Reference><Reference><Citation>Lang D., Dohle F., Terstesse M., Bangen P., August C., Pauels H.-G., Heidenreich S. Down-Regulation of Monocyte Apoptosis by Phagocytosis of Platelets: Involvement of a Caspase-9, Caspase-3, and Heat Shock Protein 70-Dependent Pathway. J. Immunol. 2002;168:6152&#x2013;6158. doi: 10.4049/jimmunol.168.12.6152.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.168.12.6152</ArticleId><ArticleId IdType="pubmed">12055227</ArticleId></ArticleIdList></Reference><Reference><Citation>Passacquale G., Vamadevan P., Pereira L., Hamid C., Corrigall V., Ferro A. Monocyte-platelet interaction induces a pro-inflammatory phenotype in circulating monocytes. PLoS ONE. 2011;6:e25595. doi: 10.1371/journal.pone.0025595.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0025595</ArticleId><ArticleId IdType="pmc">PMC3192052</ArticleId><ArticleId IdType="pubmed">22022418</ArticleId></ArticleIdList></Reference><Reference><Citation>Ammon C., Kreutz M., Rehli M., Krause S.W., Andreesen R. Platelets induce monocyte differentiation in serum-free coculture Abstract: Terminal maturation of blood mono- cytes (MO) in vitro and in vivo into macrophages connections that may be important for MO differen- and/or with platelets. Ammon C, Kreutz M, Rehli M, Krause SW, Andreesen R. Platelets induce monocyte differentiation in serum-free coculture. J. Leukoc. Biol. 1998;63:469&#x2013;476.</Citation><ArticleIdList><ArticleId IdType="pubmed">9544577</ArticleId></ArticleIdList></Reference><Reference><Citation>Gudbrandsdottir S., Hasselbalch H.C., Nielsen C.H. Activated platelets enhance IL-10 secretion and reduce TNF-&#x3b1; secretion by monocytes. J. Immunol. 2013;191:4059&#x2013;4067. doi: 10.4049/jimmunol.1201103.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1201103</ArticleId><ArticleId IdType="pubmed">24048901</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartzkopff F., Petersen F., Grimm T.A., Brandt E. CXC chemokine ligand 4 (CXCL4) down-regulates CC chemokine receptor expression on human monocytes. Innate Immun. 2012;18:124&#x2013;139. doi: 10.1177/1753425910388833.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1753425910388833</ArticleId><ArticleId IdType="pubmed">21088050</ArticleId></ArticleIdList></Reference><Reference><Citation>Linke B., Schreiber Y., Picard-Willems B., Slattery P., N&#xfc;sing R.M., Harder S., Geisslinger G., Scholich K. Activated Platelets Induce an Anti-Inflammatory Response of Monocytes/Macrophages through Cross-Regulation of PGE2 and Cytokines. Mediators Inflamm. 2017;2017:1463216. doi: 10.1155/2017/1463216.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2017/1463216</ArticleId><ArticleId IdType="pmc">PMC5448075</ArticleId><ArticleId IdType="pubmed">28592915</ArticleId></ArticleIdList></Reference><Reference><Citation>Bournazos S., Rennie J., Hart S.P., Dransfield I. Choice of anticoagulant critically affects measurement of circulating platelet-leukocyte complexes. Arterioscler. Thromb. Vasc. Biol. 2008;28:2&#x2013;4. doi: 10.1161/ATVBAHA.107.153387.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.107.153387</ArticleId><ArticleId IdType="pubmed">18094392</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeda Y., Marumo M., Nara H., Feng Z.-G., Asao H., Wakabayashi I. Selective induction of anti-inflammatory monocyte-platelet aggregates in a model of pulsatile blood flow at low shear rates. Platelets. 2016;27:583&#x2013;592. doi: 10.3109/09537104.2016.1153616.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/09537104.2016.1153616</ArticleId><ArticleId IdType="pubmed">27078265</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xfc;megi A., Antal-Szalm&#xe1;s P., Aleksza M., Kov&#xe1;cs I., Sipka S., Zeher M., Kiss E., Szegedi G. Glucocorticosteroid therapy decreases CD14-expression and CD14-mediated LPS-binding and activation of monocytes in patients suffering from systemic lupus erythematosus. Clin. Immunol. 2005;117:271&#x2013;279. doi: 10.1016/j.clim.2005.09.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2005.09.002</ArticleId><ArticleId IdType="pubmed">16316784</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukherjee R., Kanti Barman P., Kumar Thatoi P., Tripathy R., Kumar Das B., Ravindran B. Non-Classical monocytes display inflammatory features: Validation in Sepsis and Systemic Lupus Erythematous. Sci. Rep. 2015;5:1&#x2013;14. doi: 10.1038/srep13886.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep13886</ArticleId><ArticleId IdType="pmc">PMC4566081</ArticleId><ArticleId IdType="pubmed">26358827</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuentes Q. E., Fuentes Q. F., Andr&#xe9;s V., Pello O.M., de Mora J.F., Palomo G. I. Role of platelets as mediators that link inflammation and thrombosis in atherosclerosis. Platelets. 2012;24:1&#x2013;8. doi: 10.3109/09537104.2012.690113.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/09537104.2012.690113</ArticleId><ArticleId IdType="pubmed">22671308</ArticleId></ArticleIdList></Reference><Reference><Citation>Alcocer Varela J., Laffon A., Alarcon Segovia D. Defective monocyte production of, and T lymphocyte response to, interleukin-1 in the peripheral blood of patients with systemic lupus erythematosus. Clin. Exp. Immunol. 1984;55:125&#x2013;132.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1535785</ArticleId><ArticleId IdType="pubmed">6229371</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan W., Dimartino S.J., Redecha P.B., Ivashkiv L.B., Salmon J.E. Systemic lupus erythematosus monocytes are less responsive to interleukin-10 in the presence of immune complexes. Arthritis Rheum. 2011;63:212&#x2013;218. doi: 10.1002/art.30083.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.30083</ArticleId><ArticleId IdType="pmc">PMC3014998</ArticleId><ArticleId IdType="pubmed">20954190</ArticleId></ArticleIdList></Reference><Reference><Citation>Linker-Israeli M., Deans R.J., Wallace D.J., Prehn J., Ozeri-Chen T., Klinenberg J.R. Elevated levels of endogenous IL-6 in systemic lupus erythematosus. J. Immunol. 2015;147:117&#x2013;123.</Citation><ArticleIdList><ArticleId IdType="pubmed">2051017</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrmann M., Voll R.E., Zoller O.M., Hagenhofer M., Ponner B.B., Kalden J.R. Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. Arthritis Rheum. 1998;41:1241&#x2013;1250. doi: 10.1002/1529-0131(199807)41:7&lt;1241::AID-ART15&gt;3.0.CO;2-H.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1529-0131(199807)41:7&lt;1241::AID-ART15&gt;3.0.CO;2-H</ArticleId><ArticleId IdType="pubmed">9663482</ArticleId></ArticleIdList></Reference><Reference><Citation>Munoz L.E., Gaipl U.S., Franz S., Sheriff A., Voll R.E., Kalden J.R., Herrmann M. SLE - A disease of clearance deficiency? Rheumatology. 2005;44:1101&#x2013;1107. doi: 10.1093/rheumatology/keh693.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keh693</ArticleId><ArticleId IdType="pubmed">15928001</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Z.Y., Chien P., Indik Z.K., Schreiber A.D. Human platelet Fc&#x3b3;RIIA and phagocytes in immune-complex clearance. Mol. Immunol. 2011;48:691&#x2013;696. doi: 10.1016/j.molimm.2010.11.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molimm.2010.11.017</ArticleId><ArticleId IdType="pmc">PMC3086791</ArticleId><ArticleId IdType="pubmed">21168221</ArticleId></ArticleIdList></Reference><Reference><Citation>Linge P., Fortin P.R., Lood C., Bengtsson A.A., Boilard E. The non-haemostatic role of platelets in systemic lupus erythematosus. Nat. Rev. Rheumatol. 2018;14:195&#x2013;213. doi: 10.1038/nrrheum.2018.38.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrrheum.2018.38</ArticleId><ArticleId IdType="pubmed">29559714</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon D.I., Chen Z., Xu H., Li C.Q., Dong J.F., McIntire L.V., Ballantyne C.M., Zhang L., Furman M.I., Berndt M.C., et al. Platelet glycoprotein Ib&#x3b1; is a counterreceptor for the leukocyte integrin Mac-1 (CD11b/CD18) J. Exp. Med. 2000;192:193&#x2013;204. doi: 10.1084/jem.192.2.193.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.192.2.193</ArticleId><ArticleId IdType="pmc">PMC2193258</ArticleId><ArticleId IdType="pubmed">10899906</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindmark E., Tenno T., Siegbahn A. Role of platelet P-selectin and CD40 ligand in the induction of monocytic tissue factor expression. Arterioscler. Thromb. Vasc. Biol. 2000;20:2322&#x2013;2328. doi: 10.1161/01.ATV.20.10.2322.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.ATV.20.10.2322</ArticleId><ArticleId IdType="pubmed">11031222</ArticleId></ArticleIdList></Reference><Reference><Citation>Silverstein R.L., Asch A.S., Nachman R.L. Glycoprotein IV mediates thrombospondin-dependent platelet-monocyte and platelet-U937 cell adhesion. J. Clin. Investig. 1989;84:546&#x2013;552. doi: 10.1172/JCI114197.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI114197</ArticleId><ArticleId IdType="pmc">PMC548914</ArticleId><ArticleId IdType="pubmed">2474571</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulz C., Von Br&#xfc;hl M.L., Barocke V., Cullen P., Mayer K., Okrojek R., Steinhart A., Ahmad Z., Kremmer E., Nieswandt B., et al. EMMPRIN (CD147/basigin) mediates platelet-monocyte interactions in vivo and augments monocyte recruitment to the vascular wall. J. Thromb. Haemost. 2011;9:1007&#x2013;1019. doi: 10.1111/j.1538-7836.2011.04235.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1538-7836.2011.04235.x</ArticleId><ArticleId IdType="pubmed">21320284</ArticleId></ArticleIdList></Reference><Reference><Citation>Rong M., Wang C., Wu Z., Zeng W., Zheng Z., Han Q., Jia J., Li X., Zhu P. Platelets induce a proinflammatory phenotype in monocytes via the CD147 pathway in rheumatoid arthritis. Arthritis Res. Ther. 2014;16:478. doi: 10.1186/s13075-014-0478-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13075-014-0478-0</ArticleId><ArticleId IdType="pmc">PMC4298113</ArticleId><ArticleId IdType="pubmed">25404518</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Gils J.M., Zwaginga J.J., Hordijk P.L. Molecular and functional interactions among monocytes, platelets, and endothelial cells and their relevance for cardiovascular diseases. J. Leukoc. Biol. 2008;85:195&#x2013;204. doi: 10.1189/jlb.0708400.</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.0708400</ArticleId><ArticleId IdType="pubmed">18948548</ArticleId></ArticleIdList></Reference><Reference><Citation>Larsen E., Celi A., Gilbert G.E., Furie B.C., Erban J.K., Bonfanti R., Wagner D.D., Furie B. PADGEM protein: A receptor that mediates the interaction of activated platelets with neutrophils and monocytes. Cell. 1989;59:305&#x2013;312. doi: 10.1016/0092-8674(89)90292-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(89)90292-4</ArticleId><ArticleId IdType="pubmed">2478294</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelson A.D., Barnard M.R., Krueger L.A., Valeri C.R., Furman M.I. Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin: Studies in baboons, human coronary intervention, and human acute myocardial infarction. Circulation. 2001;104:1533&#x2013;1537. doi: 10.1161/hc3801.095588.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/hc3801.095588</ArticleId><ArticleId IdType="pubmed">11571248</ArticleId></ArticleIdList></Reference><Reference><Citation>Christersson C., Johnell M., Siegbahn A. Tissue factor and IL8 production by P-selectin-dependent platelet-monocyte aggregates in whole blood involves phosphorylation of Lyn and is inhibited by IL10. J. Thromb. Haemost. 2008;6:986&#x2013;994. doi: 10.1111/j.1538-7836.2008.02956.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1538-7836.2008.02956.x</ArticleId><ArticleId IdType="pubmed">18363812</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong C.H.Y., Jenne C.N., Petri B., Chrobok N.L., Kubes P. Nucleation of platelets with blood-borne pathogens on Kupffer cells precedes other innate immunity and contributes to bacterial clearance. Nat. Immunol. 2013;14:785&#x2013;792. doi: 10.1038/ni.2631.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.2631</ArticleId><ArticleId IdType="pmc">PMC4972575</ArticleId><ArticleId IdType="pubmed">23770641</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarma J., Laan C.A., Alam S., Jha A., Fox K.A.A., Dransfield I. Increased platelet binding to circulating monocytes in acute coronary syndromes. Circulation. 2002;105:2166&#x2013;2171. doi: 10.1161/01.CIR.0000015700.27754.6F.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.0000015700.27754.6F</ArticleId><ArticleId IdType="pubmed">11994250</ArticleId></ArticleIdList></Reference><Reference><Citation>Harding S.A., Sommerfield A.J., Sarma J., Twomey P.J., Newby D.E., Frier B.M., Fox K.A.A. Increased CD40 ligand and platelet &#x2013; monocyte aggregates in patients with type 1 diabetes mellitus. Atherosclerosis. 2004;176:321&#x2013;325. doi: 10.1016/j.atherosclerosis.2004.05.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.atherosclerosis.2004.05.008</ArticleId><ArticleId IdType="pubmed">15380455</ArticleId></ArticleIdList></Reference><Reference><Citation>Pamuk G.E., Nur&#x131; Pamuk &#xd6;., &#xd6;r&#xfc;m H., Arican &#xd6;., Turgut B., Dem&#x131;r M. Elevated platelet-monocyte complexes &#x131;n pat&#x131;ents w&#x131;th psor&#x131;at&#x131;c arthr&#x131;t&#x131;s. Platelets. 2009;20:493&#x2013;497. doi: 10.3109/09537100903165174.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/09537100903165174</ArticleId><ArticleId IdType="pubmed">19852688</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki J., Hamada E., Shodai T., Kamoshida G., Kudo S., Itoh S., Koike J., Nagata K., Irimura T., Tsuji T. Cytokine secretion from human monocytes potentiated by P-selectin-mediated cell adhesion. Int. Arch. Allergy Immunol. 2013;160:152&#x2013;160. doi: 10.1159/000339857.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000339857</ArticleId><ArticleId IdType="pubmed">23018521</ArticleId></ArticleIdList></Reference><Reference><Citation>Da Costa Martins P., Van Den Berk N., Ulfman L.H., Koenderman L., Hordijk P.L., Zwaginga J.J. Platelet-Monocyte Complexes Support Monocyte Adhesion to Endothelium by Enhancing Secondary Tethering and Cluster Formation. Arterioscler. Thromb. Vasc. Biol. 2004;24:193&#x2013;199. doi: 10.1161/01.ATV.0000106320.40933.E5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.ATV.0000106320.40933.E5</ArticleId><ArticleId IdType="pubmed">14615387</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawley K.L., Cruz A.R., Benjamin S.J., La Vake C.J., Cervantes J.L., LeDoyt M., Ramirez L.G., Mandich D., Fiel-Gan M., Caimano M.J., et al. IFN&#x3b3; enhances CD64-potentiated phagocytosis of Treponema pallidum opsonized with human syphilitic serum by human macrophages. Front. Immunol. 2017;8:1&#x2013;18. doi: 10.3389/fimmu.2017.01227.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.01227</ArticleId><ArticleId IdType="pmc">PMC5633599</ArticleId><ArticleId IdType="pubmed">29051759</ArticleId></ArticleIdList></Reference><Reference><Citation>Andonegui G., Kerfoot S.M., McNagny K., Ebbert K.V.J., Patel K.D., Kubes P. Platelets express functional Toll-like receptor-4. Blood. 2005;106:2417&#x2013;2423. doi: 10.1182/blood-2005-03-0916.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2005-03-0916</ArticleId><ArticleId IdType="pubmed">15961512</ArticleId></ArticleIdList></Reference><Reference><Citation>Semple J.W., Aslam R., Kim M., Speck E.R., Freedman J. Brief report Platelet-bound lipopolysaccharide enhances Fc receptor&#x2013;mediated phagocytosis of IgG-opsonized platelets. Blood. 2007;109:4803&#x2013;4806. doi: 10.1182/blood-2006-12-062695.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2006-12-062695</ArticleId><ArticleId IdType="pubmed">17299089</ArticleId></ArticleIdList></Reference><Reference><Citation>St&#xe5;hl A.L., Svensson M., M&#xf6;rgelin M., Svanborg C., Tarr P.I., Mooney J.C., Watkins S.L., Johnson R., Karpman D. Lipopolysaccharide from enterohemorrhagic Escherichia coli binds to platelets through TLR4 and CD62 and is detected on circulating platelets in patients with hemolytic uremic syndrome. Blood. 2006;108:167&#x2013;176. doi: 10.1182/blood-2005-08-3219.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2005-08-3219</ArticleId><ArticleId IdType="pmc">PMC1895830</ArticleId><ArticleId IdType="pubmed">16514062</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang G., Han J., Welch E.J., Ye R.D., Voyno-Yasenetskaya T.A., Malik A.B., Du X., Li Z. Lipopolysaccharide stimulates platelet secretion and potentiates platelet aggregation via TLR4/MyD88 and the cGMP-dependent protein kinase pathway. J. Immunol. 2009;182:7997&#x2013;8004. doi: 10.4049/jimmunol.0802884.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.0802884</ArticleId><ArticleId IdType="pmc">PMC2787095</ArticleId><ArticleId IdType="pubmed">19494325</ArticleId></ArticleIdList></Reference><Reference><Citation>Skrzeczy&#x144;ska-Moncznik J., Bzowska M., Loseke S., Grage-Griebenow E., Zembala M., Pryjma J. Peripheral blood CD14high CD16+ monocytes are main producers of IL-10. Scand. J. Immunol. 2008;67:152&#x2013;159. doi: 10.1111/j.1365-3083.2007.02051.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-3083.2007.02051.x</ArticleId><ArticleId IdType="pubmed">18201370</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirose S., Lin Q., Ohtsuji M., Nishimura H., Verbeek J.S. Monocyte subsets involved in the development of systemic lupus erythematosus and rheumatoid arthritis. Int. Immunol. 2019;31:687&#x2013;696. doi: 10.1093/intimm/dxz036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/intimm/dxz036</ArticleId><ArticleId IdType="pmc">PMC6794944</ArticleId><ArticleId IdType="pubmed">31063541</ArticleId></ArticleIdList></Reference><Reference><Citation>Marsik C., Mayr F., Cardona F., Schaller G., Wagner O.F., Jilma B. Endotoxin down-modulates P-selectin glycoprotein ligand-1 (PSGL-1, CD162) on neutrophils in humans. J. Clin. Immunol. 2004;24:62&#x2013;65. doi: 10.1023/B:JOCI.0000018064.13793.83.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/B:JOCI.0000018064.13793.83</ArticleId><ArticleId IdType="pubmed">14997035</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang H., Duan Z., Li D., Li D., Wang Z., Ren L., Shen T., Shao Y. Higher levels of circulating monocyte-platelet aggregates are correlated with viremia and increased sCD163 levels in HIV-1 infection. Cell. Mol. Immunol. 2015;12:435&#x2013;443. doi: 10.1038/cmi.2014.66.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cmi.2014.66</ArticleId><ArticleId IdType="pmc">PMC4496539</ArticleId><ArticleId IdType="pubmed">25109683</ArticleId></ArticleIdList></Reference><Reference><Citation>Davenpeck K.L., Brummet M.E., Hudson S.A., Mayer R.J., Bochner B.S. Activation of Human Leukocytes Reduces Surface P-Selectin Glycoprotein Ligand-1 (PSGL-1, CD162) and Adhesion to P-Selectin In Vitro. J. Immunol. 2000;165:2764&#x2013;2772. doi: 10.4049/jimmunol.165.5.2764.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.165.5.2764</ArticleId><ArticleId IdType="pubmed">10946308</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Lee P.Y., Reeves W.H. Monocyte and macrophage abnormalities in systemic lupus erythematosus. Arch. Immunol. Ther. Exp. (Warsz). 2010;58:355&#x2013;364. doi: 10.1007/s00005-010-0093-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00005-010-0093-y</ArticleId><ArticleId IdType="pmc">PMC3785254</ArticleId><ArticleId IdType="pubmed">20676786</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Blanc J., Lordkipanidz&#xe9; M. Platelet Function in Aging. Front. Cardiovasc. Med. 2019;6:1&#x2013;8. doi: 10.3389/fcvm.2019.00109.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2019.00109</ArticleId><ArticleId IdType="pmc">PMC6692461</ArticleId><ArticleId IdType="pubmed">31448291</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsiari C.G., Liossis S.N.C., Souliotis V.L., Dimopoulos A.M., Manoussakis M.N., Sfikakis P.P. Aberrant expression of the costimulatory molecule CD40 ligand on monocytes from patients with systemic lupus erythematosus. Clin. Immunol. 2002;103:54&#x2013;62. doi: 10.1006/clim.2001.5172.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/clim.2001.5172</ArticleId><ArticleId IdType="pubmed">11987985</ArticleId></ArticleIdList></Reference><Reference><Citation>Boilard E., Blanco P., Nigrovic P.A. Platelets: Active players in the pathogenesis of arthritis and SLE. Nat. Rev. Rheumatol. 2012;8:534&#x2013;542. doi: 10.1038/nrrheum.2012.118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrrheum.2012.118</ArticleId><ArticleId IdType="pubmed">22868927</ArticleId></ArticleIdList></Reference><Reference><Citation>Zamora C., Toniolo E., Diaz-Torn&#xe9; C., Cant&#xf3; E., Magallares B., Ortiz M.A., Perea L., Corominas H., Vidal S. Association of Platelet Binding to Lymphocytes with B Cell Abnormalities and Clinical Manifestations in Systemic Lupus Erythematosus. Mediators Inflamm. 2019;2019:1&#x2013;12. doi: 10.1155/2019/2473164.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2019/2473164</ArticleId><ArticleId IdType="pmc">PMC6421767</ArticleId><ArticleId IdType="pubmed">30944545</ArticleId></ArticleIdList></Reference><Reference><Citation>Morel Y., Truneh A., Sweet R.W., Olive D., Costello R.T. The TNF Superfamily Members LIGHT and CD154 (CD40 Ligand) Costimulate Induction of Dendritic Cell Maturation and Elicit Specific CTL Activity. J. Immunol. 2001;167:2479&#x2013;2486. doi: 10.4049/jimmunol.167.5.2479.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.167.5.2479</ArticleId><ArticleId IdType="pubmed">11509586</ArticleId></ArticleIdList></Reference><Reference><Citation>Li N., Ji Q., Hjemdahl P. Platelet-lymphocyte conjugation differs between lymphocyte subpopulations. J. Thromb. Haemost. 2006;4:874&#x2013;881. doi: 10.1111/j.1538-7836.2006.01817.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1538-7836.2006.01817.x</ArticleId><ArticleId IdType="pubmed">16634758</ArticleId></ArticleIdList></Reference><Reference><Citation>Llorente L., Richaud-Patin Y., Wijdenes J., Alcocer-Varela J., Maillot M.C., Durand-Gasselin I., Fourrier B.M., Galanaud P., Emilie D. Spontaneous production of interleukin-10 by B lymphocytes and monocytes in systemic lupus erythematosus. Eur. Cytokine Netw. 1993;4:421&#x2013;427.</Citation><ArticleIdList><ArticleId IdType="pubmed">8186374</ArticleId></ArticleIdList></Reference><Reference><Citation>Llorente L., Richaud-Patin Y., Garc&#xed;a-Padilla C., Claret E., Jakez-Ocampo J., Cardiel M.H., Alcocer-Varela J., Grangeot-Keros L., Alarc&#xf3;n-Segovia D., Wijdenes J., et al. Clinical and biologic effects of anti-interleukin-10 monoclonal antibody administration in systemic Lupus erythematosus. Arthritis Rheum. 2000;43:1790&#x2013;1800. doi: 10.1002/1529-0131(200008)43:8&lt;1790::AID-ANR15&gt;3.0.CO;2-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1529-0131(200008)43:8&lt;1790::AID-ANR15&gt;3.0.CO;2-2</ArticleId><ArticleId IdType="pubmed">10943869</ArticleId></ArticleIdList></Reference><Reference><Citation>Uchida M., Ooka S., Goto Y., Suzuki K., Fujimoto H., Ishimori K., Matsushita H., Takakuwa Y., Kawahata K. Anti-IL-10 antibody in systemic lupus erythematosus. Open Access Rheumatol. Res. Rev. 2019;11:61&#x2013;65. doi: 10.2147/OARRR.S191953.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/OARRR.S191953</ArticleId><ArticleId IdType="pmc">PMC6440452</ArticleId><ArticleId IdType="pubmed">30988645</ArticleId></ArticleIdList></Reference><Reference><Citation>Go N.F., Castle B.E., Barrett R., Kastelein R., Dang W., Mosmann T.R., Moore K.W., Howard M. Interleukin 10, a novel B cell stimulatory factor: Unresponsiveness of X chromosome-linked immunodeficiency B cells. J. Exp. Med. 1990;172:1625&#x2013;1631. doi: 10.1084/jem.172.6.1625.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.172.6.1625</ArticleId><ArticleId IdType="pmc">PMC2188770</ArticleId><ArticleId IdType="pubmed">2124252</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy Y., Brouet J.C. Interleukin-10 prevents spontaneous death of germinal center B cells by induction of the bcl-2 protein. J. Clin. Investig. 1994;93:424&#x2013;428. doi: 10.1172/JCI116977.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI116977</ArticleId><ArticleId IdType="pmc">PMC293803</ArticleId><ArticleId IdType="pubmed">8282815</ArticleId></ArticleIdList></Reference><Reference><Citation>Houssiau F.A., Vanden Berghe M., Devogelaer J.P., Lefebvre C., Lambert M., Renauld J.C. Serum interleukin 10 titers in systemic lupus erythematosus reflect disease activity. Lupus. 1995;4:393&#x2013;395. doi: 10.1177/096120339500400510.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/096120339500400510</ArticleId><ArticleId IdType="pubmed">8563734</ArticleId></ArticleIdList></Reference><Reference><Citation>Conti F., Ceccarelli F., Perricone C., Massaro L., Marocchi E., Miranda F., Spinelli F.R., Truglia S., Alessandri C., Valesini G. Systemic Lupus Erythematosus with and without Anti-dsDNA Antibodies: Analysis from a Large Monocentric Cohort. Mediators Inflamm. 2015;2015:328078.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4438145</ArticleId><ArticleId IdType="pubmed">26063969</ArticleId></ArticleIdList></Reference><Reference><Citation>Satoh M., Hamamoto T., Shibata T., Katoh M., Ashihara M., Takahashi M., Ishitani K., Natsume I., Abe Y., Yoshida S., et al. An Evaluation on the 1982 Revised Criteria for the Classification of Systemic Lupus Erythematosus. Jpn. J. Clin. Immunol. 1987;10:186&#x2013;193. doi: 10.2177/jsci.10.186.</Citation><ArticleIdList><ArticleId IdType="doi">10.2177/jsci.10.186</ArticleId></ArticleIdList></Reference><Reference><Citation>Guzm&#xe1;n J., Cardiel M.H., Arce-Salinas A., S&#xe1;nchez-Guerrero J., Alarc&#xf3;n-Segovia D. Measurement of disease activity in systemic lupus erythematosus. Prospective validation of 3 clinical indices. J. Rheumatol. 1992;19:1551&#x2013;1558.</Citation><ArticleIdList><ArticleId IdType="pubmed">1464867</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziegler-Heitbrock L., Hofer T.P.J. Toward a refined definition of monocyte subsets. Front. Immunol. 2013;4:1&#x2013;5. doi: 10.3389/fimmu.2013.00023.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2013.00023</ArticleId><ArticleId IdType="pmc">PMC3562996</ArticleId><ArticleId IdType="pubmed">23382732</ArticleId></ArticleIdList></Reference><Reference><Citation>Zamora C., Cant&#xf3; E., Nieto J.C., Angels Ortiz M., Juarez C., Vidal S. Functional consequences of CD36 downregulation by TLR signals. Cytokine. 2012;60:257&#x2013;265. doi: 10.1016/j.cyto.2012.06.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2012.06.020</ArticleId><ArticleId IdType="pubmed">22795952</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>